You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

window of opportunity

Showing 1 - 25 of 3,224
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
  • Black Raspberry
  • (no location specified)
Oct 16, 2023

Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)

Not yet recruiting
  • Colorectal Carcinoma (CRC)
  • Endometrial Carcinoma (EC)
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Nov 8, 2023

Breast Cancer Trial (Giredestrant, Giredestrant plus triptorelin, Anastrozole plus triptorelin)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 13, 2023

Gliomas Trial in Houston (Ulixertinib)

Not yet recruiting
  • Gliomas
  • Houston, Texas
    M D Anderson Cancer Center
Apr 12, 2023

Brain Metastases, Adult Trial in Durham (Patritumab deruxtecan)

Not yet recruiting
  • Brain Metastases, Adult
  • Patritumab deruxtecan
  • Durham, North Carolina
    Duke University Medical Center
Jan 19, 2023

Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Badalona, Sant Cugat Del Vallès, Barcelona (Elacestrant)

Completed
  • Breast Cancer
  • Hormone Receptor Positive Breast Carcinoma
  • Badalona, Barcelona, Spain
  • +3 more
Oct 25, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Essen, Germany
    University Hospital Essen
Nov 2, 2022

Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 22, 2023

Endometrial Cancer, Uterine Cancer Trial in Chapel Hill (Pembrolizumab, Hysterectomy)

Recruiting
  • Endometrial Cancer
  • Uterine Cancer
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Sep 27, 2022

Breast Cancer Trial in Hershey (Acute Exercise)

Not yet recruiting
  • Breast Cancer
  • Acute Exercise
  • (no location specified)
Jun 17, 2022

Breast Cancer Trial (GSK3326595)

Completed
  • Breast Cancer
  • London, Ontario, Canada
    St. Joseph's Health Care London
Oct 24, 2022

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)

Not yet recruiting
  • Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Oct 30, 2023

NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Iowa City, Iowa
    University of Iowa
Oct 10, 2023

Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Aug 4, 2023

Tobacco Smoking, Pregnancy Trial in Cluj-Napoca (Adapted/enhanced MAPS)

Completed
  • Tobacco Smoking
  • Pregnancy
  • Adapted/enhanced MAPS
  • Cluj-Napoca, Cluj, Romania
    Babes-Bolyai University
Apr 14, 2022

Bladder Cancer, Bladder Trial in Houston (UGN-201)

Recruiting
  • Bladder Cancer
  • Bladder
  • Houston, Texas
    M D Anderson Cancer Center
Jul 11, 2022

Muscle Invasive Bladder Carcinoma Trial (FL-101)

Withdrawn
  • Muscle Invasive Bladder Carcinoma
  • (no location specified)
Aug 17, 2022

Head and Neck Squamous Cell Cancer Trial in London (BYL719)

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • London, Ontario, Canada
    London Health Sciences Centre, London Regional Cancer Program
Jun 14, 2022

Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)

Active, not recruiting
  • Colorectal Cancer
  • Resectable Colorectal Carcinoma
  • Trastuzumab deruxtecan
  • +4 more
  • Milan, Lombardia/MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023

Pancreatic Ductal Adenocarcinoma Trial in Durham (HA Chemotherapy)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • HA Chemotherapy
  • Durham, North Carolina
    Duke University Health System
Nov 22, 2022

Breast Cancer Trial in Tucson (Rucaparib)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
    University of Arizona Cancer Center
Feb 24, 2022

Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

Not yet recruiting
  • Breast Cancer
  • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
  • Ottawa, Ontario, Canada
  • +1 more
Jul 22, 2023